Submit your research today!
Your valuable research in Expert Opinion on Biological Therapy - Biosimilar
About the special issue
A biosimilar is a biological medicine that has been shown not to have any clinically meaningful differences from the originator medicine in terms of quality, safety, and efficacy. Where regulatory agencies have already recommended the originator biological medicine, the same guidance will normally apply to a biosimilar of that originator.
Importantly, the advent of multiple biosimilars of originator drugs provides a major opportunity to reduce cost, which can help to support patient access to biological therapies.
With contributions from world-class key opinion leaders from across academia and industry, the issue will a one-stop shop for all things biosimilars. The Editors are particularly keen to consider studies relating to health economics, bioequivalence and real-world evidence, though commentaries in the form of editorials, reviews and perspective articles are also encouraged.
By publishing in Expert Opinion on Biological Therapy you will:
- Gain recognition from an international audience and increase your opportunities for future collaboration
- Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
- Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
- Increase the discoverability of your research with MEDLINE listings and more